Skip to main content

Advertisement

SpringerLink
Log in

High Expression of Angiopoietin-like Protein 4 in Advanced Colorectal Cancer and its Association with Regulatory T Cells and M2 Macrophages

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Colorectal cancer (CRC) is one of the most aggressive tumours in the human digestive system. Most CRC patients have poor prognosis due to metastasis and recurrence. Angiopoietin-like 4 (ANGPTL4) is involved in tumour development. Regulatory T (Treg) cells and M2 macrophages promote tumour growth and metastasis. Herein, we explored the changes of ANGPTL4 expression in CRC patients at different stages and observed whether in situ tumour-Treg and -M2 macrophages are correlated with ANGPTL4 expression. Serum ANGPTL4 (sANGPTL4) levels of 70 CRC patients and 10 healthy controls were detected by ELISA. ANGPTL4, Foxp3 and CD163 expression levels in CRC tissues were measured by immunohistochemistry. Recombinant ANGPTL4 (rANGPTL4) proteins were further added into cell-culture systems for induction of Treg cells and M2 macrophages. The results showed both sANGPTL4 and in situ tumour-ANGPTL4 expression levels increased in Dukes C–D stage CRC patients. Foxp3+ and CD163+ cells in tumour tissue sections were also more intensive in Dukes C–D stage patients than in Dukes A–B stage patients. Foxp3+ and CD163+ cells in tumour tissues were positively correlated with both tissue and sANGPTL4 expression (P < 0.01). Recombinant ANGPTL4 promoted the induction of murine Treg cells and M2 macrophages ex vivo. Therefore, elevated ANGPTL4 expression could be a marker for advanced CRC. Treg cell and M2 macrophage induction could be one of the mechanisms of tumour promotion mediated by ANGPTL4.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mody K, Baldeo C, Bekaii-Saab T (2018) Antiangiogenic therapy in colorectal Cancer. Cancer J 24:165–170

    Article  Google Scholar 

  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  Google Scholar 

  3. Santulli G (2014) Angiopoietin-like proteins: a comprehensive look. Front Endocrinol (Lausanne) 5: 4 (eCollection 2014) 5

  4. Zhu P, Goh YY, Chin HF, Kersten S, Tan NS (2012) Angiopoietin-like 4: a decade of research. Biosci Rep 32:211–219

    Article  CAS  Google Scholar 

  5. Sadeghabadi ZA, Nourbakhsh M, Alaee M, Larijani B, Razzaghy-Azar M (2018) Peroxisome proliferator-activated receptor gamma expression in peripheral blood mononuclear cells and angiopoietin-like protein 4 levels in obese children and adolescents. J Endocrinol Investig 41:241–247

    Article  CAS  Google Scholar 

  6. Tjeerdema N, Georgiadi A, Jonker JT, van Glabbeek M, Alizadeh Dehnavi R, Tamsma JT, Smit JW, Kersten S, Rensen PC (2014) Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes. BMJ Open Diabetes Res Care 2:e000034

    Article  Google Scholar 

  7. Tan MJ, Teo Z, Sng MK, Zhu P, Tan NS (2012) Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res 10:677–688

    Article  CAS  Google Scholar 

  8. Kim SH, Park YY, Kim SW, Lee JS, Wang D, DuBois RN (2011) ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res 71:7010–7020

    Article  CAS  Google Scholar 

  9. Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC, Pal M, Lam CR, Boukamp P, Pan JY, Tan SH (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(−):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19:401–415

    Article  CAS  Google Scholar 

  10. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949

    Article  CAS  Google Scholar 

  11. Rőszer T (2015) Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediat Inflamm 2015:816460

    Article  Google Scholar 

  12. Hesketh M, Sahin KB, West ZE, Murray RZ (2017) Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci 18

    Article  CAS  Google Scholar 

  13. Nakayama T, Hirakawa H, Shibata K, Nazneen A, Abe K, Nagayasu T, Taguchi T (2011) Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis. Oncol Rep 25:929–935

    Article  CAS  Google Scholar 

  14. Xiao W, Yin M, Wu K, Lu G, Deng B, Zhang Y, Qian L, Jia X, Ding Y, Gong W (2017) High-dose wogonin exacerbates DSS-induced colitis by up-regulating effector T cell function and inhibiting Treg cell. J Cell Mol Med 21:286–298

    Article  CAS  Google Scholar 

  15. Wang K, Vella AT (2016) Regulatory T cells and Cancer: a two-sided story. Immunol Investig 45:797–812

    Article  CAS  Google Scholar 

  16. Young PP, Ardestani S, Li B (2010) Myeloid cells in Cancer progression: unique subtypes and their roles in tumor growth, vascularity and host immune suppression. Cancer Microenviron 4:1–11

    Article  Google Scholar 

  17. Goh YY, Pal M, Chong HC, Zhu P, Tan MJ, Punugu L, Tan CK, Huang RL, Sze SK, Tang MB, Ding JL, Kersten S, Tan NS (2010) Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing. J Biol Chem 285:32999–33009

    Article  CAS  Google Scholar 

  18. Izraely S, Ben-Menachem S, Sagi-Assif O, Meshel T, Marzese DM, Ohe S, Zubrilov I, Pasmanik-Chor M, Hoon DSB (2017) ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis. Oncotarget 8:75778–75796

    Article  Google Scholar 

  19. Shafik NM, Mohamed DA, Bedder AE, El-Gendy AM (2015) Significance of tissue expression and serum levels of angiopoietin-like protein 4 in breast Cancer progression: link to NF-κB /P65 activity and pro-inflammatory cytokines. Asian Pac J Cancer Prev 16:8579–8587

    Article  Google Scholar 

  20. Ma T, Jham BC, Hu J, Friedman ER, Basile JR, Sodhi A, Montaner S (2010) Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma. Infectious Agents and Cancer 5(Suppl 1):A84

    Article  Google Scholar 

  21. Liao Y, Lu W, Che Q, Yang T, Qiu H, Zhang H, He X, Wang J, Qiu M, Zou Y, Gu W, Wan X (2014) SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level. PLoS One 9:e99907

    Article  Google Scholar 

  22. Hata S, Nomura T, Iwasaki K, Sato R, Yamasaki M, Sato F, Mimata H (2017) Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer. Oncol Rep 38:120–128

    Article  CAS  Google Scholar 

  23. Yi J, Pan BZ, Xiong L, Song HZ (2013) Clinical significance of angiopoietin-like protein 4 expression in tissue and serum of esophageal squamous cell carcinoma patients. Med Oncol 30:680

    Article  Google Scholar 

  24. Huang Z, Xie J, Lin S, Li S, Huang Z, Wang Y, Ye J (2016) The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma. Arch Oral Biol 71:144–149

    Article  CAS  Google Scholar 

  25. El-Shal AS, Zidan HE, Rashad NM, Wadea FM (2017) Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma. Cytokine 96:75–86

    Article  CAS  Google Scholar 

  26. Chen JW, Luo YJ, Yang ZF, Wen LQ, Huang L (2018) Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer. Oncol Rep 39:1739–1746

    CAS  PubMed  Google Scholar 

  27. Kubo H, Kitajima Y, Kai K, Nakamura J, Miyake S, Yanagihara K, Morito K, Tanaka T, Shida M, Noshiro H (2016) Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer. Oncol Lett 11:1026–1034

    Article  CAS  Google Scholar 

  28. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, Mekid H, Mir LM, Opolon P, Corvol P, Monnot C, Germain S (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A 103:18721–18726

    Article  CAS  Google Scholar 

  29. Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating Foxp3 regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5:15179

    Article  CAS  Google Scholar 

  30. Fujimoto H, Saito Y, Ohuchida K, Kawakami E, Fujiki S, Watanabe T, Ono R, Kaneko A, Takagi S, Najima Y (2018) Deregulated mucosal immune surveillance through gut-associated regulatory T cells and PD-1 + T cells in human colorectal Cancer. J Immunol 200:3291–3303

    Article  CAS  Google Scholar 

  31. Litwitz-Salomon E, Malyshkina A, Schimmer S, Dittmer U (2018) The cytotoxic activity of natural killer cells is suppressed by IL-10 regulatory T cells during acute retroviral infection. Front Immunol 9:1947

    Article  Google Scholar 

  32. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ (2007) CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8:1353–1362

    Article  CAS  Google Scholar 

  33. Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25:129–141

    Article  CAS  Google Scholar 

  34. Xu P, Fan W, Zhang Z, Wang J, Wang P, Li Y, Yu M (2017) The clinicopathological and prognostic implications of Foxp3+ regulatory T cells in patients with colorectal cancer: a meta-analysis. Front Physiol 8:950

    Article  Google Scholar 

  35. Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, Ginanneschi C, Tsang KY, Licchetta A, Mannucci S, Loiacono L, Tassone P, Francini G, Tagliaferri P (2010) Regulatory (Foxp3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother 33:435–441

    Article  Google Scholar 

  36. Yoon HH, Orrock JM, Foster NR, Sargent DJ, Smyrk TC, Sinicrope FA (2012) Prognostic impact of Foxp3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas. PLoS One 7:e42274

    Article  CAS  Google Scholar 

  37. Ladoire S, Martin F, Ghiringhelli F (2011) Prognostic role of Foxp3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60:909–918

    Article  CAS  Google Scholar 

  38. Lee CC, Lin JC, Hwang WL, Kuo YJ, Chen HK, Tai SK, Lin CC, Yang MH (2018) Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization. Nat Commun 9:3763

    Article  Google Scholar 

  39. Lan J, Sun L, Xu F, Liu L, Hu F, Song D, Hou Z, Wu W, Luo X, Wang J, Yuan X, Hu J, Wang G (2019) M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer. Cancer Res 79:146–158

    Article  CAS  Google Scholar 

  40. Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS (2010) The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 8:13

    Article  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundations (No.81873866, No.81671547, and No.81471547) of China, the National Natural Science Foundation of Jiangsu province in China (No. BK20160479), the “Six peaks” Talent Project, and the “333” Talent Project in Jiangsu Province.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Affiliated Hospital, Yangzhou University, Yangzhou, 225001, People’s Republic of China

    Shuaiyang Zhou, Jin Tu, Guotao Lu, Yanbing Ding, Bing Deng, Weiming Xiao & Weijuan Gong

  2. Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, 225001, People’s Republic of China

    Shuaiyang Zhou, Jin Tu, Guotao Lu, Yu Zhang, Weiming Xiao & Weijuan Gong

  3. Department of Basic Medicine, School of Medicine, Yangzhou University, Yangzhou, 225001, People’s Republic of China

    Shizhen Ding, Zhijie Lin, Yanbing Ding, Bing Deng & Weijuan Gong

  4. Jiangsu Key Laboratory of Zoonosis, Yangzhou, 225001, People’s Republic of China

    Yu Zhang, Weiming Xiao & Weijuan Gong

  5. Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou, 225001, People’s Republic of China

    Yu Zhang, Weiming Xiao & Weijuan Gong

Authors
  1. Shuaiyang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shizhen Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guotao Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhijie Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanbing Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bing Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Weiming Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Weijuan Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Weiming Xiao or Weijuan Gong.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, S., Tu, J., Ding, S. et al. High Expression of Angiopoietin-like Protein 4 in Advanced Colorectal Cancer and its Association with Regulatory T Cells and M2 Macrophages. Pathol. Oncol. Res. 26, 1269–1278 (2020). https://doi.org/10.1007/s12253-019-00695-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00695-0

Keywords

Search

Navigation